Outcome of Patients with Borderline Resectable Pancreatic Cancer in the Contemporary Era of Neoadjuvant Chemotherapy

INTRODUCTION: Approximately, 20% of patients with pancreatic ductal adenocarcinoma have resectable disease at diagnosis. Given improvements in locoregional and systemic therapies, some patients with borderline resectable pancreatic cancer (BRPC) can now undergo successful resection. The outcomes of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Gastrointest Surg
Main Authors: Javed, Ammar A., Wright, Michael J., Siddique, Ayat, Blair, Alex B., Ding, Ding, Burkhart, Richard A., Makary, Martin, Cameron, John L., Narang, Amol, Herman, Joseph, Zheng, Lei, Laheru, Daniel, Weiss, Matthew J., Wolfgang, Christopher, He, Jin
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6329638/
https://ncbi.nlm.nih.gov/pubmed/30242644
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11605-018-3966-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados